Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$27.74
-1.90-6.41%
Last update: Oct 16, 4:44 PM
$27.74
-1.90-6.41%
Pharvaris NV (PHVS) Stock Price, Quote, News & History
PHVSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Pharvaris (NASDAQ:PHVS) through any online brokerage.
Other companies in Pharvaris’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Pharvaris has a consensus price target of $50.44.
The stock price for Pharvaris (NASDAQ: PHVS) is $27.74 last updated October 16, 2026 at 4:44 PM EDT.
There are no upcoming dividends for Pharvaris.
Pharvaris does not have any upcoming earnings scheduled.
There is no upcoming split for Pharvaris.
Pharvaris is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
